Fluctuations and the Rate-Limiting Step of Peptide-Induced Membrane Leakage  by Mazzuca, C. et al.
Biophysical Journal Volume 99 September 2010 1791–1800 1791Fluctuations and the Rate-Limiting Step of Peptide-Induced Membrane
LeakageC. Mazzuca,† B. Orioni,† M. Coletta,‡ F. Formaggio,§ C. Toniolo,§ G. Maulucci,{ M. De Spirito,{ B. Pispisa,†
M. Venanzi,† and L. Stella†*
†Dipartimento di Scienze e Tecnologie Chimiche and ‡Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Universita` di Roma Tor
Vergata, Rome, Italy; §Dipartimento di Scienze Chimiche, Universita` di Padova, Padua, Italy; and {Istituto di Fisica, Facolta` di Medicina e
Chirurgia, Universita` Cattolica del Sacro Cuore, Rome, ItalyABSTRACT Peptide-induced vesicle leakage is a common experimental test for the membrane-perturbing activity of antimi-
crobial peptides. The leakage kinetics is usually very slow, requiring minutes to hours for complete release of vesicle contents,
and exhibits a biphasic behavior. We report here that, in the case of the peptaibol trichogin GA IV, all processes involved in
peptide-membrane interaction, such as peptide-membrane association, peptide aggregation, and peptide translocation, take
place on a timescale much shorter than the leakage kinetics. On the basis of these findings, we propose a stochastic model
in which the leakage kinetics is determined by the discrete nature of a vesicle suspension: peptides are continuously exchanging
among vesicles, producing significant fluctuations over time in the number of peptide molecules bound to each vesicle, and in the
formation of pores. According to this model, the fast initial leakage is caused by vesicles that contain at least one pore after the
peptides are randomly distributed among the liposomes, whereas the slower release is associated with the time needed to occa-
sionally reach in an intact vesicle the critical number of bound peptides necessary for pore formation. Fluctuations due to peptide
exchange among vesicles therefore represent the rate-limiting step of such a slow mechanism.INTRODUCTIONAntimicrobial peptides (AMPs) are a major component of
the innate defense system that is shared by organisms
throughout the phylogenetic tree, including humans (1),
and represent the most ancient and efficient weapon against
microbial pathogens. Although some AMPs have multiple
functions (2), their mechanism of antibacterial activity is
based mainly on association with the plasma membrane of
the pathogens and perturbation of its permeability (3–5),
and this process usually does not involve any specific
receptor (6–8). For these reasons, antibiotic peptides are
the subject of intense research aimed at the creation of a
new class of antiinfective therapeutics to address the growing
problem of pathogenic organisms that have multiple resis-
tance to traditional antimicrobial agents (1,9).
Because the cell membrane is the main target of AMPs,
several studies have focused on their interaction with model
phospholipid bilayers (10), and one of the most common
assays for their membrane activity is based on the detection
of peptide-induced release of liposome contents (11). Typi-
cally, these experiments involve the entrapment of a fluores-
cent dye in the aqueous lumen of unilamellar vesicles at
a self-quenching concentration (12). The addition of an
AMP induces leakage of the fluorophore from the lipo-
somes. Concomitantly, its dilution in the outer volume
abolishes the self-quenching phenomenon, and the leakage
process can be followed by the increase in the fluorescence
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0006-3495/10/09/1791/10 $2.00Obviously, a quantitative analysis of the peptide-induced
leakage kinetics can potentially provide several insights into
the mechanism of pore formation. For this reason, several
studies have attempted to achieve amechanistic understanding
of the leakage kinetics. The release curves determined in these
experiments for many different AMPs, toxins, and even
amyloid peptides (13) in most cases share two peculiar
characteristics: 1), they are surprisingly slow, requiring
minutes to hours for complete leakage, whereas simple
physical considerations show that the time needed to empty
a 100 nm liposome through a single pore is much shorter
(14); and 2), they exhibit a strongly nonexponential behavior,
with a fast initial leakage that progressively slows down.
These two properties have been observed in peptides
such as melittin (15–19), mastoparan (20,21), cecropin (22),
a-toxin (23), d-lysin (24,25), transportan 10 (26), alamethi-
cin (16,27), gramicidin (16), magainin (28–30), pardaxin
(31,32), and model amphipathic peptides (33–35). It is
important to note that DeGrado and co-workers (15) showed
that the leakage kinetics induced in cells (e.g., hemolysis) is
remarkably similar to liposome release, strengthening the
relevance of these observations.
The fact that these studies span almost 30 years, often
focusing on the same peptides, shows that a satisfactory
explanation of the experimentally observed behavior is still
elusive. Several hypotheses have been put forward regarding
the rate-limiting step of the slow leakage process, including
peptide-membrane binding (31), a conformational transition
of the peptide (19), peptide aggregation (15,17,24,25,29,
34,36), pore formation (27,22,30), pore opening (37), and
peptide translocation across the bilayer (21,37). Similarly,doi: 10.1016/j.bpj.2010.07.010
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progressive slowing down of the kinetics, such as peptide
inactivation due to a conformational transition (28),
aggregation (15), or translocation across the membrane
(21,26,35).
In this work we systematically evaluate all of the possibil-
ities for the rate-limiting step by taking as an example a very
well characterized peptide, the peptaibol trichogin GA IV
(see Scheme 1). Detailed spectroscopic studies on the fluo-
rescent analog F10 of this peptide have demonstrated that
it forms aggregates both in water and in the membrane,
and that aggregation in the bilayer is accompanied by
insertion into the hydrophobic core of the membrane and
by pore formation (38–41). These studies also showed that
the four populated species (monomer and aggregate, in
both water and the membrane) are characterized by signifi-
cantly different fluorescence lifetimes and quantum yields
of the fluorene label (38,40). This property led to a quantita-
tive determination of their relative populations (38,40), and
allowed us to follow their kinetic behavior in this study.
The results reported here indicate that the origin of the
slow leakage observed in a population of vesicles very likely
resides in a largely overlooked but very basic property of the
experimental system, i.e., its discrete nature. Many studies,
mainly by the groups of Schwarz (17,19,20,27), Nir (32,34),
and Almeida (22,25,26,30), proposed quantitative models to
describe the leakage kinetics. However, in most of these
cases the role of fluctuations was neglected. By contrast,
a vesicle (or cell) suspension is obviously a discrete system,
and the release of the contents of each vesicle is not influ-
enced by the other liposomes in the sample. A liposome is
a nanoscopic system and the number of peptides or the
number of pores in each vesicle can be rather small, well
below the thermodynamic limit. Recently, a large body of
studies demonstrated that the kinetics of systems formed
by discrete, small entities can be dramatically different
from that predicted for continuous systems, owing to the
significant fluctuations caused by the low number of mole-
cules involved (42–47).
Some previous studies considered that significant varia-
tions can occur in the number of peptides bound to each
vesicle (18,19,27,34), but the consequences of this observa-
tion on the leakage kinetics were not taken into account in
their full scope. For instance, none of these studies consid-
ered that the number of peptides associated with a specific
vesicle can fluctuate over time due to peptide exchange
among vesicles. Here we propose a model based on these
fluctuations that provides an explanation for the peculiar
features of the peptide-induced vesicle leakage kinetics.Trichogin GA IV Oct-Aib-Gly-Leu-Aib-Gly-G
F10 Oct-Aib-Gly-Leu-Aib-Gly-G
SCHEME 1 Primary structures of trichogin GA IVand its fluorescent analog
diaminobutyric acid; Fmc, fluorenyl-9-methylcarbonyl.
Biophysical Journal 99(6) 1791–1800MATERIALS AND METHODS
Materials
All lipids were purchased from Avanti Polar Lipids (Alabaster, AL), and
carboxyfluorescein (CF) and Sephadex G-50 were obtained from Sigma
(St. Louis, MO). Texas-Red dextran (average molecular weight (MW):
10,000; neutral form) was obtained from Invitrogen (Eugene, OR). Spectro-
scopic-grade chloroform and methanol (Carlo Erba, Milano, Italy) were
used. Polyvinyl alcohol (average MW: 22,000; 88% hydrolyzed) and Triton
X-100 were purchased from Acros (Geel, Belgium).
Peptide synthesis and liposome preparation
Synthesis of peptide F10 and preparation of large unilamellar vesicles
(LUVs) were performed as previously described (38). All liposomes
were formed by egg phosphatidylcholine and cholesterol (1:1 molar ratio).
The total lipid concentration (phospholipids þ cholesterol) is reported.
Liposomes containing the fluorescent lipid 1-palmitoyl-2-[6-((7-nitro-
benz-2-oxa-1,3-diazol-4-yl)amino)caproyl]-L-a-phosphatidylcholine (C6-
NBD-PC) in the external layer were prepared by adding an aliquot of
a concentrated ethanolic solution of C6-NBD-PC to preformed, unlabeled
vesicles to obtain a 0.5% label molar fraction (48). The final ethanol
concentration was always <1%.
Giant unilamellar vesicles (GUVs) were prepared by the electroforma-
tion method (49), and 3 mM CF or 18 mM Texas-Red-labeled dextran
were entrapped inside the GUVs. To independently observe the GUV
content and the lipid membrane, GUVs entrapping CF molecules were
marked with 1% molar ratio of the rhodamine-labeled lipid, 1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl)
(N-Rho-PE), and GUVs containing Texas-Red-labeled dextran were
marked with 5% of the fluorescent lipid 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine-N-(7-nitrobenz-2-oxa 1,3-diazol-4-yl) (NBD-PE).
Peptide-induced leakage
Peptide-induced membrane permeability was determined by measuring the
fractional release of CF entrapped inside liposomes, as previously reported
(38). Steady-state fluorescence spectra were carried out on a SPEX Fluoro-
max 2 fluorimeter (Edison, NJ). Temperature was controlled to 25C by
a thermostated cuvette holder. To minimize peptide adsorption on cell
walls, UV-grade polymethylmethacrylate cuvettes were treated overnight
with a 5% (w/w) water solution of polyvinyl alcohol (38).
Stopped-flow experiments
Stopped-flow experiments were performed on a SX.18 MV apparatus
(Applied Photophysics, Leatherhead, UK) with a fluorescence detector
and a nominal mixing time of 1 ms. Temperature was controlled to 25C.
Mixing of asymmetric volumes (1:10 alcoholic peptide solution/aqueous
liposome solution) was employed. Samples were excited at 265 nm, and
emission was collected using a cutoff filter at 305 nm or 385 nm.Light scattering
Experiments were carried out with a commercial ALV light-scattering
spectrometer (ALV, Langen, Germany) with a Coherent Innova 70 argon
ion laser (Coherent Italia, Milano, Italy) operating at a wavelength ofly-Leu-Aib-Gly-Ile-Lol 
ly-Leu-Aib-Gly-Dab(Fmc)-Lol 
F10. Oct, n-octanoyl; Aib, a-aminoisobutyric acid; Lol, leucinol; Dab, a,g-
Fluctuations in Vesicle Leakage Kinetics 1793488 nm at 100 mW. The scattering cell was immersed in a refractive index
matching fluid (toluene) maintained at 21 5 0.1C. For each sample,
dynamic light scattering data were collected and acquired typically for
a duration of 5 min for 1–3 angular runs. All samples were investigated
at seven different angles from 30 to 150. The number-weighted particle
size distribution was recovered by direct inversion of the intensity autocor-
relation function (50).RESULTS
Release kinetics
Fig. 1 shows the vesicle release kinetics obtained at different
peptide concentrations. Several observations can be made
from these data: 1), the release curves do not follow a simple
exponential behavior; 2), the release curves are extremely
slow, extending for many tens of minutes; and 3), the release
kinetics is strongly dependent on the peptide/lipid ratio. These
curves are characterized by a fast phase in which a significant
fraction of the vesicle content is released, and by a much
slower leakage phase. Of interest, all curves lead to complete
leakage after a sufficient period of time. For instance, a 2.3
mM peptide concentration causes the release of only 17% of
the vesicle contents in 20min but leads to an almost complete
leakage after 48 h, whereas control experiments show that
spontaneous release in the absence of F10 is negligible in
this time frame.Binding, aggregation, and translocation kinetics
We followed peptide binding to the membrane and the
formation of aggregates by taking advantage of the intrinsic
fluorescence of the synthetic trichogin GA IV analog F10.
Because the four species populated by F10 (monomeric
and aggregated peptide, in both water and the membraneFIGURE 1 Kinetics of CF release after addition of peptide F10 to an
LUV suspension. [Lipid] ¼ 0.2 mM and [F10] ¼ 1.2 mM, 2.3 mM,
3.7 mM, 4.7 mM, 6.9 mM, 10.8 mM (from bottom to top). The dotted lines
are the best fit to the data with the model described here.phase) are characterized by a different quantum yield and
fluorescent lifetime (38), both the water to membrane parti-
tion and peptide aggregation are accompanied by a variation
in the fluorescence intensity signal.
Fig. 2 shows the results of stopped-flow experiments
performed by mixing a methanolic concentrated solution
of the peptide with a solution of lipid vesicles. The fluores-
cence signal exhibited an initial decrease due to peptide
aggregation, followed by a strong increase resulting from
the water to membrane partition. Of interest, all signal vari-
ations were completed within ~30 s, i.e., on a timescale
much shorter than that of the vesicle leakage experiments.
Previous studies showed that F10 is able to rapidly trans-
locate across the bilayer, but they did not determine the
timescale of this process (39). To further characterize this
process, we also performed stopped-flow experiments with
vesicles labeled with the fluorescent lipid analog C6-
NBD-PC.FIGURE 2 Stopped-flow experiments on F10-membrane interaction.
Two different timescales are reported in panels A and B. For the experi-
ments, 30 mL of a concentrated F10 methanol solution were mixed with
300 mL of an aqueous suspension of LUVs. Final concentrations:
[F10] ¼ 0.5 mM, [lipid] ¼ 0.2 mM. Continuous lines: F10 was added to
unlabeled vesicles and fluorene emission was collected. Dotted lines: F10
was added to vesicles labeled on the external leaflet of the bilayer with
0.5% C6-NBD-PC, and NBD emission was collected.
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energy transfer acceptor for fluorene, with a Fo¨rster radius
(51) of 24 A˚ (39). The vesicles were labeled with C6-
NBD-PC on the external leaflet of the lipid bilayer only.
Under the conditions used, no lipid flip-flop takes place
(39), ensuring that the lipid labeling asymmetry is main-
tained. In our stopped-flow experiments, we followed the
changes in NBD emission related to peptide association to
the membrane. The water to membrane partition of the
peptide induced a significant increase in NBD emission,
which followed the same kinetics observed for the fluorene
fluorescence. The subsequent decrease in NBD emission
was caused by the translocation of a fraction of the peptide
from the outer leaflet to the unlabeled layer. However, even
the translocation process was completed in ~50 s, i.e., on
a timescale much faster than that of the vesicle leakage
process.
These findings prove that the water to membrane parti-
tion, peptide aggregation, and peptide translocation are not
the rate-limiting steps of the slow vesicle leakage process,
since they are several orders of magnitude faster.Leakage of a single vesicle
Another possible explanation for the long timescale
observed in the leakage experiments is that the rate-limiting
step is connected to the time needed by a single vesicle to
completely release its contents after the formation of at least
one peptide-induced pore.
An estimate of this timescale can be obtained by applying
the first Fick’s law, which describes the diffusion-mediated
flow of fluorescent molecules through open pores as:
½CinðtÞ  Cout ¼ ½Cinð0Þ  Coute tf (1)
4 ¼ 4
3
pR3
d
ApD0
(2)
where Cin and Cout stand for the fluorophore concentrations
at the internal and external pore bounds, respectively; D0 is
the diffusion coefficient of the fluorophore in the pore; d is
the thickness of the membrane; Ap is the total pore cross-
sectional area; and R is the vesicle radius (14). In the leakage
experiments described in Fig. 1, R ~50 nm (i.e., the radius of
the pores of polycarbonate extrusion filters), d ¼ 4 nm (52),
and D0 ¼ 2.17  10 8 nm2/s (53). By assuming a minimal
pore diameter of 1 nm (corresponding to the approximate
size of the CF molecules), one can estimate Ap for a single
pore to be higher than 0.8 nm2. Substitution of these param-
eters into the above equations, gives f ~10 ms, indicating
that the time needed to empty a single vesicle can be
excluded as a possible rate-limiting step.
It is worth mentioning that this value represents just
a very rough estimate of the timescale of the vesicle-
emptying process because it is based on several approxima-Biophysical Journal 99(6) 1791–1800tions. The most severe is that the molecules diffuse
freely inside the pore, without any impedance, and this
very likely leads to a significant underestimation of f.
However, a direct assessment of the timescale of this param-
eter can be experimentally obtained by employing GUVs
(i.e., liposomes with a diameter of several micrometers)
that can be observed directly in the optical microscope.
Such an experiment (reported in Fig. S1 of the Supporting
Material) showed that F10 induced the complete release of
the vesicle contents without destroying the membrane,
thus providing direct evidence for the formation of pores.
Of interest, no leakage was observed when a larger molecule
(Texas-Red-labeled dextran; average MW: 10,000) was
entrapped inside the GUVs, indicating that the pore diam-
eter is approximately 1–4 nm, which corresponds to the
approximate size of the CF and dextran molecules, respec-
tively. This result confirms previous studies performed
with LUVs (38).
In the case of CF, the leakage of GUV contents was
completed in <10 min. This also includes the time needed
for peptide diffusion from the site of addition to the vesicle
under observation (since no stirring was possible in the
observation chamber) and for pore formation. The diameter
of the LUVs employed in the leakage experiments of Fig. 1
was ~500 times smaller than that of the GUV, and Eq. 2 indi-
cates that the time needed to unload a single vesicle after
pore formation increases with the vesicle radius. Therefore,
the results of the GUV experiment indicate that the time
needed to unload a single LUV after pore formation is
much shorter than the timescale of the leakage curves
reported in Fig. 1.Size dependence of the vesicle leakage
Further information on the leakage process from a popula-
tion of vesicles was obtained by studying the dependence
of the LUV release kinetics on the liposome size. The
vesicle size distribution for three different preparations,
obtained by extrusion through membranes with pore radii
of 50, 100, and 200 nm, was determined by light scattering
experiments. The actual average radius was 56, 83, and
140 nm, respectively, with a standard deviation of the size
distribution of ~5 nm. The leakage curves were determined
for these three vesicle preparations at the same peptide and
lipid concentrations to obtain the same membrane-bound
peptide surface density in all cases.
These curves, reported in Fig. 3, show that the release
velocity and the fraction of vesicle contents released in
a given time from a population of vesicles increase with
vesicle size. This counterintuitive result is in contrast to
the size dependence for the release from a single vesicle
after one pore is formed (Eq. 2).
This finding confirms the view that the release of vesicle
contents after pore formation in each liposome is not the
rate-limiting step in the ensemble leakage experiments,
FIGURE 3 Leakage kinetics as a function of vesicle size. The inset
shows the initial release velocity (calculated for the first 20 s of the leakage
process) as a function of the actual average radius of the vesicles.
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surface area must be involved.FIGURE 4 (A) F10-induced CF release ([lipid ] ¼ 0.2 mM) stopped by
the addition of 2 mM unloaded LUVs. (B) F10-induced CF release. Curve
a: F10 was incubated with LUVs not containing CF, and at time zero CF-
loaded LUVs were added. Curve b: F10 was added directly to a mixture of
loaded and unloaded LUVs.Peptide exchange between vesicles
To further characterize all processes involved in the vesicle
leakage kinetics, we studied the exchange of peptides
between vesicles to verify whether F10 is able to rapidly
distribute in the whole vesicle population.
Fig. 4 A shows the leakage curve obtained by adding
F10 to 0.2 mM CF-filled vesicles. At the time indicated
by the arrow, a large excess (10:1) of CF-free vesicles was
added, resulting in a cessation of the release process
(19,28). Peptide exchange between liposomes caused a
high dilution of F10 concentration in the membrane, and
peptide concentration dropped below the threshold needed
for pore formation.
Further confirmation of the rapid peptide exchange
between vesicles was obtained by the following experiment:
F10 was mixed with unlabeled lipid vesicles at a lipid
concentration sufficient to induce an almost complete
membrane association of the peptide. After complete equil-
ibration was achieved, CF-containing vesicles were added to
this sample and their leakage kinetics was recorded
(22,24,30). It started immediately and followed a behavior
very similar to that observed when the peptide was added
directly to a mixture of CF-loaded and unloaded vesicles,
confirming that the peptide bound to the unlabeled
vesicles in the first curve was able to distribute in the whole
vesicle population (Fig. 4 B). Furthermore, this experiment
indicates that the pores do not suffer any significant inacti-
vation after the initial peptide binding to the membrane,
a hypothesis that is often invoked to explain the biphasic
behavior of the leakage kinetics (15,19,35) or incomplete
leakage (24,25).Theoretical model
The vesicle as a system far from the thermodynamic limit
The experiments described above ruled out several
processes as possible candidates for the rate-limiting step
in vesicle leakage: peptide-membrane association, homoge-
neous peptide distribution in the whole vesicle population,
peptide translocation across the bilayer, peptide aggregation
to form pores, and leakage of the vesicle contents once the
pore is formed.
However, the observation that peptides exchange rapidly
among vesicles led us to consider that whereas the leakage
experiments were performed on a macroscopic sample, this
system is formed by much smaller discrete entities, i.e., the
lipid vesicles. Peptide exchange between vesicles causes
continuous fluctuations in the number of peptide molecules
bound to each vesicle. The relatively small size of a lipo-
some ensures that the number of bound peptides is far
from the thermodynamic limit. Therefore, fluctuations in
this number cannot be neglected. Considering that the
pore-formation process is a cooperative phenomenon driven
by peptide concentration in the membrane, the fluctuationsBiophysical Journal 99(6) 1791–1800
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even larger than those in the number of vesicle-bound
peptide molecules. At any given time, some vesicles contain
pores while others do not. This situation explains the fast
phase of the leakage curves, during which time the vesicles
that already contain at least one pore rapidly release their
contents.
If no peptide exchange between vesicles were present, no
further leakage would be observed after this fast phase.
However, our data show that even when the peptide concen-
tration is so low that the fast phase is very small, the vesicles
contents are completely released, but on a much longer
timescale. This observation reflects the fact that, thanks to
fluctuations, the threshold concentration for peptide aggre-
gation and pore formation can be reached. In our opinion,
these fluctuations represent the rate-determining step for
the depletion of each liposome, and the slow overall kinetics
is due to the long period of time that inactive vesicles have
to wait before fluctuations lead to an amount of bound
peptide sufficient to induce pore formation and leakage.
Peptide exchange among vesicles is fast, and therefore so
are the fluctuations in the number of peptides bound to
each liposome. However, peptide aggregation, which is
also a relatively fast process, requires that a critical number
of peptides be present on a given vesicle. Therefore, the
appearance of a pore in a specific liposome is definitely
a much rarer event.
The complete characterization of the membrane interac-
tion of the fluorescent trichogin analog F10 achieved in our
previous works (38,39) now allows us to test this hypothesis.
Using time-resolved measurements, we previously deter-
mined the fraction of peptide molecules that are
membrane-bound and participate in the peptide aggregates
that constitute the pores (38). These data can be used to calcu-
late the average number of peptidemolecules participating in
aggregates for each liposome. In the concentration range
used in the leakage experiments reported in Fig. 1, this
number varies from ~50 to 600 peptide monomers, and
depending on the size of the aggregates, the number of
pores can be much lower (40). Furthermore, it is important
to stress that not necessarily all aggregates constitute an
open pore, and that therefore the fluctuations in the number
of pores in a given vesicle are definitely significant.
In the following section we develop a kinetic model based
on these ideas.Stochastic kinetic model
As shown in our previous studies (38–40), the concentration
of membrane-bound trichogin aggregates (which constitute
the pores) is regulated by aggregation equilibria (both in
water and in the membrane phase) and by the water to
membrane partition of the peptide. Here, we show that
the water to membrane partition, peptide aggregation, pore
formation, and release of the contents of those vesicles inBiophysical Journal 99(6) 1791–1800which at least one pore is formed take place on a timescale
much faster than the leakage process. Therefore, it is reason-
able to assume, for the sake of simplicity, that they can
be considered instantaneous, as compared to the release
kinetics. According to this hypothesis, after a very fast
initial transient phase the peptide-membrane and peptide-
peptide interaction processes are at equilibrium. As a result,
the total number of pores Np in the whole macroscopic
vesicle suspension is constant: fluctuations in this number
are negligible due to the high numbers of peptides and vesi-
cles in the macroscopic sample. For the same reason, fluctu-
ations in all properties of the overall vesicle suspension are
negligible, so that in the following derivation only average
values will be considered. The only significant fluctuations
are those taking place in the number of pores present in
the small system constituted by a specific vesicle: peptides
are continuously exchanging among vesicles, leading to
the formation (and disassembly) of pores in each specific
liposome. Because the total number of pores is constant,
we will regard this latter process as simply an exchange of
pores among vesicles.
We define kex as the rate of exchange of pores among
vesicles, i.e., on average, each pore goes from one liposome
to another kex times per second. Obviously, kexwill be a func-
tion of the rate constants of the individual underlying molec-
ular processes (such as water-membrane peptide partition
and aggregation), but for the present treatment it is sufficient
to introduce this overall, operationally defined constant. Let
us consider an infinitesimal time interval dt, so short that the
probability that a pore will change more than one vesicle in
dt is negligible. On average, the total number of pores
exchanging vesicles in dt is therefore Np kexdt.
We now define Nv as the total number of vesicles, and Nf
as the number of full vesicles at any given time. Therefore,
the fraction of full vesicles F is Nf /Nv, which is also the
probability that a pore-exchanging vesicle will end up in
a liposome that is still full. As a consequence, the total
number of pores that move from one vesicle to another,
ending up in a full liposome, will be given on average by:
Nf
Nv
Npkexdt ¼ Nf nkexdt (3)
where n is the average number of pores per vesicle. If dt is
small enough, the probability that two pores that change
vesicles will end up in the same liposome is negligible.
Therefore, Nf nkexdt is also the average number of full vesi-
cles receiving a pore in dt and emptying in that time interval,
since complete depletion of a pore-containing liposome is
assumed to be instantaneous (i.e., an all-or-none mecha-
nism). Thus, we can write:
dNf ¼ Nf nkexdt (4)
and
Nf ¼ Nf ð0Þentt (5)
TABLE 1 Parameters corresponding to the best fit of the
leakage data with Eq. 10
[F10] (mM) n f (s) t (s)
1.2 0.035 0.01 90 5 50 34405 40
2.3 0.145 0.01 50 5 10 30005 300
3.7 0.405 0.05 90 5 10 10005 300
4.7 1.1 5 0.2 70 5 20 16005 200
6.9 1.3 5 0.3 50 5 10 15005 100
10.8 1.9 5 0.3 28 5 2 11505 50
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zero the peptides (and therefore the pores) distribute
randomly among the vesicles. The probability of finding
a given number of pores (n) in a given vesicle will be
described by a Poisson distribution P(n). Pð0Þ ¼ en is the
probability that a vesicle has no pores, and therefore at
time zero a fraction (1  P(0)) of vesicles already have at
least one pore and become instantaneously empty. In
conclusion, Nf ð0Þ ¼ Nven, and the fraction of full vesicles
(or the fraction of liposome contents still inside vesicles) is
given by:
FðtÞ ¼ enentt (6)
The fraction of liposome contents released (R) is given by
1  F.
We verified this equation by Monte Carlo simulations in
which we explicitly considered both vesicles and pores (see
Supporting Material). At any time step dt the pores could
randomly migrate from one vesicle to another, with proba-
bility kexdt ¼ dt/t. Once a vesicle contained at least one
pore, it would instantaneously become empty. The simulated
leakage kinetics was described exactly by Eq. 6 (see Fig. S2),
a finding that confirms the correctness of its derivation.
Equation 6 captures the essential features of the experi-
mental leakage curves: a fast phase (which in Eq. 6 is instan-
taneous) followed by a slower leakage; the extent of the fast
phase, which increases with peptide concentration; and
a faster leakage with increasing n (and therefore with
increasing vesicle radius, if the surface density of peptide
is constant). However, this equation is not adequate to quan-
titatively describe the leakage curves, because the initial
phase is not instantaneous.
If the initial approximation that all processes (except fluc-
tuations) are instantaneous is removed, a less sharp initial
phase is predicted. For instance, let us assume that peptide
aggregation, water to membrane partition, and pore
formation are still instantaneous, but the time needed by
a pore-containing vesicle to release its contents cannot be
neglected. Let us first calculate the behavior of F(t) if no
fluctuations in the number of pores in each vesicle take
place. In this case the fraction of fluorophores entrapped
inside vesicles decays as:
FðtÞ ¼
XN
m¼ 0
PðmÞemtf (7)
where f is the characteristic time associated with the release
from a single pore (Eq. 2), and P(m) is the probability of
having m pores in a vesicle (14). By assuming a Poisson
distribution for P(m), one can calculate the decay in F(t):
XN ennm mt nð1et=fÞ
Average values and errors were obtained from fits to duplicate experiments.FðtÞ ¼
m¼ 0 m!
e f ¼ e (8)In Eq. 8, the average number of pores per vesicle n can
be considered constant because all processes contributing
to pore formation were assumed to equilibrate instanta-
neously, i.e., before the leakage began. According to
Eq. 8, F does not jump instantaneously to en at time zero
(as predicted by Eq. 6), but decays to this value with a relax-
ation time f.
It is now possible to consider the case in which the
leakage from pore-containing vesicles is not instantaneous,
and also peptide exchange among vesicles is at play.
Because the timescales of the two processes are very
different, we can still assume that f << t. In this case, fluc-
tuations in the number of pores in each vesicle are negligible
during the fast leakage process, and Eqs. 8 and 6 can be
easily combined to describe the overall decay of the encap-
sulated fluorophore fraction:
FðtÞ ¼ enð1et=fÞentt (9)
In this case, the fraction of liposome contents released is
RðtÞ ¼ 1 FðtÞ ¼ 1 enð1et=fÞentt (10)
To confirm that Eq. 10 correctly describes a system corre-
sponding to the assumptions described above, we performed
further stochastic Monte Carlo simulations (see Supporting
Material). In this case, a pore-containing vesicle was
allowed to empty gradually, with a rate proportional to the
number of pores, and to 1/f. The leakage kinetics simulated
by this stochastic approach was described exactly by Eq. 10
when t/f > 100. When this ratio was lower, the simulated
curves could still be fitted well by Eq. 10, but this led to
a slight underestimation in the parameters. However, for
t/f ¼ 30, the difference between simulated and recovered
parameter was <10% (see Fig. S3 and Table S1).
A fit to the release data with Eq. 10 (presented in Fig. 1,
dotted lines) provides a satisfactory description of the decay
curves. The parameters obtained from the fit are reported in
Table 1.
The most interesting result obtained from these fits is an
estimate for n, which within the range investigated increases
from 0.03 to ~2. These data can be compared with previous
results from time-resolved fluorescence experiments per-
formed at equilibrium, which determined the number ofBiophysical Journal 99(6) 1791–1800
1798 Mazzuca et al.membrane-bound peptide molecules participating in
aggregates, i.e., the peptide species that constitutes the pores
(38). As shown in Fig. 5, the two data sets are clearly
correlated. Because these two results were obtained by
completely independent measurements (kinetic versus
equilibrium), their correlation provides strong support for
the model used to describe the leakage kinetics. It is inter-
esting to note that the ratio between the two data sets
is ~300, whereas the average number of trichogin molecules
that form an aggregate is presumably on the order of 10
(38,40). This finding suggests that not all aggregates consti-
tute a pore. A critical aggregation number is probably needed
to obtain an open pore or, alternatively, peptide aggregates
could be present in both an open and a closed state.
Both t and f exhibit some variability but no definite trend
with peptide concentration, whereas according to the model
they were expected to be constant. This finding could be due
to 1), the limited reproducibility of the leakage curves, as
indicated by errors on the recovered parameters obtained
by comparing duplicate experiments; or 2), the simplifying
approximations used in the model, such as the assumption of
a monodisperse vesicle population, or the fact that only the
release process was considered in deriving Eqs. 7–10,
whereas our data show that other phenomena can influence
the kinetics in the first seconds after peptide addition. This
latter point could be also responsible for the fact that the
recovered f-values are higher than our rough theoretical
estimate (in addition to the free diffusion hypothesis
employed to derive it). In any case, all values of this param-
eter are much lower than those of t, in agreement with our
assumptions, indicating that the fluctuations in the number
of pores in each liposome, caused by peptide exchangeFIGURE 5 Correlation between the average number of pores in a single
vesicle, obtained from the fit to the leakage kinetics and the number of
membrane-bound peptide molecules participating in aggregates, deter-
mined from time-resolved fluorescence experiments at equilibrium (37).
Egg phosphatidylcholine/cholesterol LUVs, [lipid] ¼ 0.2 mM, vesicle
radius ¼ 50 nm.
Biophysical Journal 99(6) 1791–1800among vesicles, indeed represent the rate-limiting step for
the slow leakage process. Furthermore, a global fit of the
data, with linked values of f and t for all experimental
curves, is reported in the Supporting Material (Fig. S4 and
Table S2). Although the results are obviously worse than
the individual fits to each of the leakage curves, they are still
reasonable, and the recovered values of the parameters are
close to those of the individual fits.
Finally, it is interesting to note that Eq. 10 also provides
an explanation for the observed ensemble leakage behavior
as a function of vesicle radius (Fig. 3). It predicts that the
kinetics will become faster with increasing n, and therefore,
all other parameters being equal, with increasing vesicle
radius.DISCUSSION
The proposed model captures the general features of the
release kinetics observed for trichogin GA IV. Because
similar behaviors have been observed for many other
peptides, the model might have a general relevance.
Numerous studies have made the general observation of
a peptide-membrane association much faster than the
leakage timescale (22,24,30,32,34,54,55), and both theoret-
ical considerations and experimental data indicate that once
a pore is formed, a single vesicle releases its contents very
quickly. Regarding peptide aggregation, direct studies of
the kinetics of this process are scarce, but it should be
considered that membrane fluidity and the bidimensional
character of a lipid bilayer make the diffusion-limited
encounter of two membrane-bound peptide molecules
extremely fast (19). Also the increase in ensemble vesicle
leakage with vesicle size was previously observed (34),
and peptide exchange among vesicles was demonstrated in
several cases (19,22,28,30). Therefore, fluctuations induced
by peptide exchange among vesicles might indeed be the
rate-limiting step for the slow vesicle leakage in many cases.
Of more importance, in all cases in which peptides do
exchange among vesicles, the effects of fluctuations and
the discrete nature of the experimental system must be taken
into account, even though the actual situation might be more
complex than suggested by the model presented here. It
might be argued that fluctuations become insignificant
when the number of peptides bound per vesicle is rather
high, as suggested by the carpet model (6). However, in
all cases in which cooperative phenomena take place, such
as aggregation (56,57) or membrane-mediated interactions,
even small fluctuations in the vesicle-bound peptide concen-
tration can be highly amplified.
Recently, Gregory and co-workers (22) presented a
detailed study of the kinetics of membrane interaction and
vesicle leakage for cecropin A. Consistent with our findings,
they showed that all processes involved in peptide-membrane
interaction aremuch faster than the leakage timescale. There-
fore, to account for the slow release kinetics, they had to
Fluctuations in Vesicle Leakage Kinetics 1799include an additional step in their model. They defined this
rate-limiting process as the transition of each vesicle to
a pore state in which liposome contents are released. The
averagenumber of peptides bound to each vesicle in that study
is comparable to those reported here, and fluctuations may be
the origin of the chaotic pore-opening step in their model.
Several predictions of our model can be used to experi-
mentally test its applicability to a specific case, such as
the size dependence of the ensemble leakage kinetics, or
the attainment of complete leakage at very long times,
even with very low peptide concentrations. In this respect,
it is worth mentioning that some studies claimed that
leakage stopped before completion, suggesting pore inacti-
vation (21,26) and/or lack of peptide exchange among vesi-
cles (18,34). However, in some instances the reported
experimental data do not necessarily support this conclu-
sion, due to the relatively short length of the leakage curves.
Because this is a very diagnostic property for the leakage
mechanism, one should always inspect it very carefully by
acquiring leakage curves over longer times.CONCLUSIONS
From the data presented here, we can draw four major
conclusions regarding the mechanism of peptide-induced
leakage from a population of vesicles in the case of tricho-
gin GA IV:
1. All processes involved in peptide-membrane interaction
attain equilibrium on a timescale much faster than the
leakage kinetics, and therefore can be ruled out as the
rate-limiting step of this process.
2. Fluctuations in the number of aggregated peptides
associated to each liposome and induced by peptide
exchange among vesicles are significant due to the rela-
tively small size of the liposomes.
3. The stochastic model proposed here, which considers
these fluctuations as the rate-limiting process in the
slow leakage kinetics, gives a satisfactory quantitative
description of the release data.
4. The kinetic model provides an estimate for the average
number of pores per vesicle, which correlates with an
independent assessment of this quantity from equilib-
rium fluorescence data.
The kinetics of peptide-induced vesicle leakage provides
a new example of a system whose behavior is determined by
the discrete nature of the sample and by the fluctuations
caused by the relatively small size of the discrete entities,
as recently observed for different processes in cell biology
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